Hello, Guest!
  • Monday, September 16, 2024

Emergent Lands $535M HHS Smallpox Preparedness Support Contract


Jeff Brody

Emergent BioSolutions (NYSE: EBS) has received a potential 10-year, $535M contract to supply the Department of Health and Human Services with intravenous medications designed to treat patients experiencing adverse events following smallpox vaccination.

The company said Monday it will provide Vaccinia Immune Globulin Intravenous products that HHS intends to include in the U.S. Strategic National Stockpile as part of public health preparedness efforts.

HHS’ Office of the Assistant Secretary for Preparedness and Response awarded the contract with a $23M base value and includes nine-year option periods.

“VIGIV is the only product licensed by the U.S. Food and Drug Administration for the treatment of complications due to smallpox vaccination,” said Robert Kramer, president and CEO at Emergent BioSolutions.

The company will use government-provided plasma to produce VIGIV doses during the first year of contract and continue production efforts with the firm’s own plasma supply.

Emergent completed VIGIV deliveries to the Centers for Disease Control and Prevention under a one-year, $26M contract awarded in February of last year.

Video of the Day

Related Articles

Leidos’ Srini Iyer on Possibility of ‘Shadow AI’ in Health Care Sector Artificial Intelligence

Leidos’ Srini Iyer on Possibility of ‘Shadow AI’ in Health Care Sector

Srini Iyer, chief technology officer at Leidos‘ (NYSE: LDOS) health business group, said companies might look for ways to get around the reporting requirements outlined in President Biden’s executive order on the trustworthy development and use of artificial intelligence, raising the possibility of shadow AI in the health care sector, Fierce Healthcare reported Friday. Speaking

Arlington Capital Strikes Deal With Thoma Bravo for Exostar; Ben Ramundo Quoted M&A Activity

Arlington Capital Strikes Deal With Thoma Bravo for Exostar; Ben Ramundo Quoted

Private equity firm Arlington Capital Partners has agreed to purchase secure business collaboration platforms provider Exostar from software investment firm Thoma Bravo for an undisclosed sum. Washington, D.C.-based Arlington will help Exostar further expand its service offerings, drive product development and advance growth initiatives through the transaction, which is expected to be finalized by the

Potomac Officers Club Sets Date for Year’s Most Important GovCon Healthcare Event Events

Potomac Officers Club Sets Date for Year’s Most Important GovCon Healthcare Event

Potomac Officers Club, the premier organization that specializes in gathering high-profile speakers and collaborative colleagues for government contracting industry events, is excited to announce its upcoming 2023 Healthcare Summit. This highly relevant, informative day of programming will tap into the most important things happening in the healthcare industry, investigating what the government and private sector can